Clinical trials

October 22, 2025

Cosentyx® (secukinumab) achieved statistically significant and clinically meaningful sustained remission vs placebo at Week 521Trial showed reduction in…

HHealth

October 20, 2025

Image: ©Naeblys | iStock The world’s largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments…

GGenetics

New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of Color

October 14, 2025

Is an Alzheimer’s clinical trial right for you? What does it mean to enroll in an Alzheimer’s clinical…

MMedication

Common opioid is not that effective for easing chronic pain, study finds

October 10, 2025

Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new…

HHealthcare

October 6, 2025

By Patrick Wingrove, Maggie Fick and Julie Steenhuysen (Reuters) -U.S. Health Secretary Robert F Kennedy Jr. could deliver…

MMedication

FDA rejects Rexulti-Zoloft combo for PTSD

September 23, 2025

The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…

EEconomy

Draghi had a plan to save Europe’s economy. We’ve rated it, a year in – POLITICO

September 8, 2025

Joint debt: Let’s see Draghi has been a consistent advocate for EU joint borrowing of the kind carried…

Novartis Cosentyx® meets primary and all secondary endpoints in Phase III trial in patients with polymyalgia rheumatica (PMR)

Largest-ever £26 million trial launches across UK to slow Parkinson’s disease

New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of Color

Common opioid is not that effective for easing chronic pain, study finds

US Health Secretary Kennedy speeds autism drug with GSK help

FDA rejects Rexulti-Zoloft combo for PTSD

Draghi had a plan to save Europe’s economy. We’ve rated it, a year in – POLITICO